Research

Filter by Region, Sector, or Focus
UVA leaders celebrated the announcement of Amazon's decision to locate a major headquarters function in Virginia as a significant opportunity to increase our contributions to the state and to collaborate with additional Virginia universities to creat
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.
UVA's Center for Applied Biomechanics is taking a leadership role in analyzing populations with heightened vulnerability to traffic-related injury or death, specifically women and obese passengers.
A new UVA Cancer Center Without Walls initiative will empower Southwest Virginia residents to lead projects to better detect and prevent cancer in the region.
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.
EdPolicyWorks, a joint collaboration between the Curry and Batten Schools, brings together researchers from across UVA and the state to focus on important questions of educational policy and implications for the workforce.
NSF funding will allow UVA Engineering’s Link Lab to develop a new program that will train graduate students to make discoveries and then translate that knowledge into new technologies, products and services.